Skip to content
Peptides Codex

Use the arrow keys to choose a result, Enter to open it, and Escape to close.

← Home
Neuropeptide

Galanin

Galanin is a neuropeptide (30 residues in humans) that modulates neurotransmission across many brain regions. Research explores its involvement in mood, feeding, and pain-signaling pathways.

By The Peptides Codex Editorial TeamIndividual review date not recorded

Page data last changed: . Registry refreshes and identity assessments are separate from scientific content review.

Reference backbone length
30 positions
Class
Neuropeptide
Function
Neuromodulation of mood, feeding and nociception
Context
Neuroscience research

Widely distributed neuromodulator acting through GAL1–GAL3 receptors.

Part of the Neuropeptides & signaling cluster

Overview

Galanin is a neuropeptide (30 residues in humans) that modulates neurotransmission across many brain regions. Research explores its involvement in mood, feeding, and pain-signaling pathways.

Source & context

Biological / chemical source: Central and peripheral nervous system

Primary research or clinical context: Neuroscience research

Receptor subtypes

Galanin acts through three G-protein-coupled receptors (GAL1, GAL2, GAL3) with distinct distributions. This receptor diversity is a major reason galanin biology is studied in the context of appetite, seizure thresholds, and stress in experimental models.

Species length note

Human galanin is 30 amino acids, while many other species express a 29-residue amidated form. Such species differences are a recurring point of care when comparing published galanin studies.

Sequence of the selected reference form

Sequence backbone for the reference form: Human galanin(1-30), nonamidated C-terminal Ser free acid. Termini, stereochemistry and modifications are described below.

GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS

GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS

Galanin30 aa · C139H210N42O43 · ≈ 3,157.4 Da · Free L-serine carboxylic acid (-COOH)PEPTIDESCODEX.COMN-terminus →→ C-terminusG1W2T3L4N5S6A7G8Y9L10L11G12P13H14A15V16G17N18H19R+20S21F22S23D−24K+25N26G27L28T29S30nonpolarpolaracidicbasicGly / Pronon-canonical (X)Hydropathy (Kyte–Doolittle): ▮ hydrophobic (cyan) / ▮ hydrophilic (rose) · Side-chain charge at pH 7: + / −
Galanin — Structure cardDownload SVG
G1W2T3L4N5S6A7G8Y9L10L11G12P13H14A15V16G17N18H19R20S21F22S23D24K25N26G27L28T29S30
Helical wheel projection

Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.

Analyze sequences in the playground →

Structure & chemistry

Molecular identity & reference confidence

Source-supported reference

Select the experimentally isolated human 30-residue nonamidated galanin molecule. The original human pituitary study, reviewed human precursor and PubChem graph agree; this avoids transferring the usual nonhuman 29-residue amide to a human profile.

Molecular form
Human galanin(1-30), nonamidated C-terminal Ser free acid
Species
Homo sapiens
Termini (N / C)
Free alpha-amino group of glycine / Free L-serine carboxylic acid (-COOH)

Average reference mass · Molecular identity assessment: 2026-10-05

Reference policy updated: 2026-10-05

Molecular formula
C139H210N42O43
Average reference mass
≈ 3,157.4
Backbone
Human galanin(1-30), nonamidated C-terminal Ser free acid
C-terminus
Free L-serine carboxylic acid (-COOH)
Identifiers

Chemistry values: curated profile, PubChem.

Clinical development snapshot

ClinicalTrials.gov lists 3 registered studies with “Galanin” as an intervention (snapshot 2026-09-06). A registry footprint is not evidence of efficacy or approval.

Registered studies
3
Highest phase reached
Not applicable
Active in latest 100
0
Most recent update
2026-02-25
Most recently updated studies
NCTTitlePhaseStatusUpdated
NCT07434362Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic RetinopathyNot applicablecompleted2026-02-25
NCT05446025The Levels of the Orexin, Galanin and aMSH and CART in Patients With Hyperemesis Gravidarum—completed2023-02-02
NCT03230149Prevalence and Characteristics of Fabry Disease (FD) in Patients With Stroke or Small Fiber Neuropathy—completed2022-09-07
See all on ClinicalTrials.gov →
Concentration math

Galanin — reconstitution calculator

Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.

Reference form: Human galanin(1-30), nonamidated C-terminal Ser free acidAverage reference mass: 3,157.4 Da

Syringe graduation
Solution concentration
5 mg/mL5,000 mcg/mL
mcg

Enter an amount to see the volume it corresponds to.

Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.

Open the Galanin calculator on its own page →

Change log

Dated observations from the data pipeline (registry flags, trial footprints, identifiers) and editorial reviews of this profile.

  1. ChemistryPubChem formula updated to C139H210N42O43.

FAQ about Galanin

What is Galanin?+

Galanin is a neuropeptide (30 residues in humans) that modulates neurotransmission across many brain regions. Research explores its involvement in mood, feeding, and pain-signaling pathways.

What Canadian product status is recorded for Galanin?+

Canadian product status for Galanin has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.

What is the length of the selected reference form for Galanin?+

The selected reference form (Human galanin(1-30), nonamidated C-terminal Ser free acid) has 30 residues or residue-derived units in its backbone. Other forms in this family may have a different length.

Related peptides

References & further reading

  1. 1.Lu et al. (2005). Galanin receptor ligands. Neuropeptides
  2. 2.Lerner et al. (2010). Galanin and epilepsy. Exp Suppl
  3. 3.Lerner et al. (2008). Galanin and epilepsy. Cell Mol Life Sci
  4. 4.Branchek et al. (2000). Galanin receptor subtypes. Trends Pharmacol Sci
  5. 5.Picciotto (2008). Galanin and addiction. Cell Mol Life Sci
  6. 6.Iismaa et al. (1999). Galanin and galanin receptors. Results Probl Cell Differ
  7. 7.Robinson (2004). Galanin and cognition. Behav Cogn Neurosci Rev
  8. 8.Wiesenfeld-Hallin et al. (1998). Galanin in somatosensory function. Ann N Y Acad Sci
  9. 9.PubChem — compound summary for Galanin (CID 16133823)
  10. 10.UniProt — Galanin peptides, human (P22466)
  11. 11.Wikipedia — Galanin
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Galanin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.